RECORDS OF OUR EVENTS
FRENCH ACADEMIE DE PHARMACIE
New medication intelligence
february 1st 2023
French speaking vidéo
Intelligence artificielle et pharmacovigilance
Dr Irène Fermont
La révolution du médicament intelligent
Philippe Moingeon
Colloque Le Medicament Intelligent Academie Nationale de Pharmacie - Paris
Les differents process impactes par l IA en Pharmacovigilance. Utilisation des Real World Data- et cas d'etude
"
La convergence entre les sciences du médicament, les biotechnologies et l'intelligence artificielle révolutionne toutes les dimensions du cycle de vie du médicament : conception, développement, production, dispensiation, suivi de pharmacovigilance..."
COVID VACCINES AROUND THE WORLD
LATIN AMERICA 2nd PART ARGENTINA - BRAZIL - CHILE
march 23rd, 2022
INTRODUCTION
Dr Irène Fermont - Dr Raquel Herrera Comoglio
Dr Dr Raquel Herrera Comoglio,
Head of Pharmacovigilance Service, Hospital Nacional de Clínicas,
School of Medical Sciences, National University of Córdoba, Argentina
Prof Adalton Guimaraes Ribeiro,
Former Consultant in the Brazilian Health Ministry, and Professor in Faculty Oswaldo Cruz and Post Graduation Institute
QF. Adiela Saldaña, MSc
Head Pharmacovigilance Section, Public Health Institute of Chile
CONCLUSION
Dr Irène Fermont - Dr Raquel Herrera Comoglio
COVID VACCINES AROUND THE WORLD
LATIN AMERICA 1st PART COLOMBIA - CUBA - MEXICO
march 1st, 2022
INTRODUCTION
Dr Irène Fermont - Dr Raquel Herrera Comoglio
Dr Maria Acelias Marrero Miragalles, President of the Cuban Society of Pharmacology
Diadelis Ramirez
Prof Claudia Vaca-Gonzales,
Pharmaco-epidemiology, National University of Colombia
Juanita Vahos Zambrano
Safety Surveillance of Covid-19 Vaccines in Mexico: a preliminary report
Dr Fela Viso-Gurovich
Ex President of the Colegio Nacional de
Químicos Farmacéuticos Biólogos, México, A. C.
CONCLUSION
Dr Irène Fermont - Dr Raquel Herrera Comoglio
COVID VACCINES AROUND THE WORLD

INDIA
19 May 2021
Indian Vaccination Program
Dr Maya Sharma MD
Mechanism underlying COVID-19: Current scenario of vaccines
Dr.Chinmaya Mahapatra, PhD
Digitalization and Pharmacoepidemiology of the Indian vaccination program
Dr Subhrojyoti Bhowmick, MD,
ISOP Israel - WEBINARS SERIES
COVID 19-VACCINES VIGILANCE
A collaboration between
ISOP Latin America and Israeli Chapter
and SIG Vaccine
part 01 : USA
Hypersensitivity and mRNA Vaccines
Mariana Castells
Harvard Medical School
25 February 2021
ISOP Israel - COVID VACCINE
Panorama of a scientific breakthrough
I'M AN ORIGINAL CATCHPHRASE
Dr Irene Rina Fermont
Vaccin COVID : panorama d'un exploit scientifique (in French)
7 December 2020;
in the frame of Midreshet Manitou and Lilmod
Dr Irene Rina Fermont
Vaccin COVID : du decodage du virus a la vaccination (in French) Healthcare professiionals
23 December 2020;, for Healthcare professiionals
in the collaboration with MEDIF MDA et OSE
Priya Bahri interviewed by Dr. I.Fermont
(in French)
Prof Peter Pitts interviewed by Dr. I.Fermont
(in English)
Prof Gideon Koren interviewed by Dr I Fermont
(in English)
ERANIM Israel - COVID VACCINE
Interviews on TV and on social networks
Interview Dr Irene Fermont sur NEWS dans le Prime de Jean Charles Banoun le 22 mars 2022
(in French)
Allocution du Premier Ministre, Naphtali Bennett, sur I24News dans le Prime dede JC Banoun, le 2 janvier 2022
(in French)
Interview Dr Irene Fermont sur NEWS dans le Prime de Jean Charles Banoun le 2 janvier 2022
(in French)
Interview Dr Irene Fermont sur Qualita par Daniel le 12 janvier 2022
(in French)
ISOP ISRAEL - TELL US A SAFETY STORY
In English
Dr Itai Gueta Tells us a Safety Case Story
5 May 2021
Sleeping beauty, will she be awaken?
Dr Marco Tuccori Tells us a Safety Case Story
4 November2020 (English)
Severe thrombocytopenia and haemolytic anaemia associated with self-prescribed ciprofloxacin
Tell us a Safety Case Story- 8 July 2020 (English)
Prof. Ronen Loebstein: Drug Interactions with DOACS
Dr. Irene Fermont: Can we prevent Lyell &SJ syndromes?
In Hebrew
Mgr Sima Livny Tells us a Safety Case Story
17 February 2021 (Hebrew)
Three safety stories from the community
Dr Itai Gueta Tells us a Safety Case Story
18 November2020 (Hebrew)
Sleeping beauty, will she be awaken?
Tell us a Safety Case Story- 22 July 2020 (Hebrew)
Dr. Ophir Lavon Medication reconciliation
WHO-ISOP WORLD PATIENT SAFETY DAY -16 September 2020
ISOP ISRAEL was proud to open the conference
Dr. Irene Fermont. Multidisciplinary strategy
Prof.Gideon Koren, Treating the Mother, Protecting the Unborn and the Newborn
Dr. Gidi Stein, AI solution to prevent medication error: Results of the Harvard study
Dr. Gil Mileikowsky Patient empowerment: how to get out of a hospital alive!
ISOP ISRAEL
SAFETY IN THE COVID ERA SUMMITS
15 July 2020 & 2 September 2020
1st Summit: DRUG SAFETY IN THE COVID ERA -2nd part - 15 July 2020
Dr Gidi Stein; AI solution to prevent medication errors, focus on COVID era
1st Summit : DRUG SAFETY IN THE COVID ERA -1st part- 15 July 2020
Chaired by Prof.Gideon Koren 1/COVID 19 drugs in pregnancy 2/ safety profiles in drug repurposing
Keynote Lecture: Peter Pitts : The Battle Against COVID-19: Are we behind the Eight Ball?
Dr Lee Goldstein : Drugs used regularly by patients which may affect the severity of COVID19 Infection
2nd Summit DRUG SAFETY IN THE COVID ERA -2 September 2020
Chaired by Prof.Gideon Koren
Dr. Michael Cohen: medications errors reported to FDA and ISMP during COVID era
Prof Nick Sevdalis Impact of infographics on patient engagement;
Dr Marco Tuccori :Covid19 Infodemic
2nd Summit DRUG SAFETY IN THE COVID ERA -2 September 2020
Dr. Michael Cohen: presentation of ISMP : The Institute for Safe Medication Practices
ERANIM - ISRAEL
Situation de la pandémie au 22 janvier 2022.
12 janvier 2022
Qu'avons nous appris depuis 2 ans avec chaque vague et avec les vaccins? Avec plus de 6 millions d'enfants vaccinés aux USA, on peut mieux évaluer le bénéfice risque, avec une très grande quantité de données sur l'efficacité et la tolérance . Un travail collectif de la Task Force d'ERANIM Israël.
1 / 4 :OMICRON, en quoi est-ce différent des autres variants
2 / 4 : Les nouveaux traitements
